Medical Research

WebMD – Obesity’s Link to Type 2 Diabetes Not So Clear-Cut

Researchers found that the majority of people diagnosed with type 2 diabetes didn’t get the disease until they’d been overweight or obese for a number of years. What’s more, participants who maintained stable levels of overweight and eventually developed type 2 diabetes didn’t have a significant rise in their level of insulin resistance.

DiabetesHealth – Blood Sugars Linked to Memory Problems

People with diabetes of any type have experienced a very simple but meaningful truth about the disease: Blood sugar levels affect everything. It’s not just about lows and possible complications, either–those numbers can affect your mood and overall health.

Type 2 Nation – Study: “Fat-Shaming” Contributes to Obesity

A recent study provided scientific data to back up that hunch. A team of researchers measured the body mass index of 6,157 people, aged 50 or older in 2006 and again in 2010. They also asked each participant, whether overweight or not, whether they had experienced discrimination based on weight.

Seven new genetic regions linked to type 2 diabetes

DNA data was brought together from more than 48,000 patients and 139,000 healthy controls from four different ethnic groups. The research was conducted by an international consortium of investigators from 20 countries on four continents, co-led by investigators from Oxford University’s Wellcome Trust Centre for Human Genetics.

The Guardian – Scientists move closer to stem cell cure for type 1 diabetes

Researchers in California report that they have reversed the equivalent of type 1 diabetes in mice through transplants of stem cells. Their experiments have replaced cells in the pancreas damaged by the disease that are unable to make insulin.

HuffPost – Meditation 101: The Neuroscience of Why Meditation Works

There are five major categories of brain waves, each corresponding to different activities. Meditation enables us to move from higher frequency brain waves to lower frequency, which activates different centers in the brain.

EndoBarrier helps battle type-two diabetes and obesity, study says

More than 23 million people across the United States have been diagnosed with type-two diabetes. Treatment often involves surgery, medication, or both, but researchers are testing a new treatment called EndoBarrier that doesn’t require going under the knife or taking any medication.

DiabetesHealth – Gastric Bypass Surgery Cuts Heart Risk, Stroke Odds for Type 2s by 40%

According to research from the Cleveland Clinic, after gastric bypass, obese diabetes patients had a 40 percent reduced risk of experiencing a heart attack and 42 percent less risk of having a stroke.

NPR – Higher Blood Pressure At 18 Means Hardening Arteries At 40

Young people in their teens and early 20s probably aren’t thinking about heart disease. But maybe it’s time they did. People who have slightly higher blood pressure when they’re 18 to 25 are more likely to have high blood pressure and hardening of the arteries in their 40s, a study says.

DiabetesHealth – Skin Cream Could Treat Peripheral Neuropathy

The cream, which has been tested on mice in two trials, is designed to replenish GDNF, a group of cells that play a role in stimulating nerve growth. For those with small-fiber neuropathy–which reveals itself through pain and tingling in the extremities, usually the feet–the cells are lost through the degeneration of nerve endings.

One Spouse with T2DM May Increase Risk Up to 26% for Their Partner

The study looked at a total of 75,498 couples and found that having a spouse with type 2 diabetes can increase the partner’s diabetic risk by 26%. In explanation of these results, the researchers cited something called “social clustering”.

NPR – A Little Acid Turns Mouse Blood Into Brain, Heart And Stem Cells

Biologist Haruko Obokata and her colleagues at the RIKEN Center for Developmental Biology say they’ve figured out a fast, easy way to make the most powerful cells in the world — embryonic stem cells — from just one blood cell.

More Benefits Emerging for One Type of Omega-3 Fatty Acid: DHA

Study of the metabolic effects of omega-3 fatty acids, especially DHA, concludes that these compounds may have an even wider range of biological impacts than previously considered, and suggests they could be of significant value in the prevention of fatty liver disease.

DiabetesMine – Testing Your Glucose Levels Using… Saliva?

Believe it or not, there’s a new company on the scene working on a diabetes device that would use nothing more than a bit of your spit to take a glucose reading.

MNT – Discovery could lead to a test to predict later development of type 2 diabetes

A Montreal research team led by Jennifer Estall at the IRCM discovered that a protein found in muscle tissue may contribute to the development of type 2 diabetes later in life. The study’s results, published in the printed edition of the scientific journal American Journal of Physiology – Endocrinology and Metabolism, indicate that the protein […]

DiabetesInControl – Research: Can Bariatric Surgery Really Cure TII Diabetes?

A retrospective review was conducted for all patients that have undergone bariatric surgery between January 2004 and December 2007 at the Cleveland Clinic Bariatric and Metabolic Institute. These patients had type 2 diabetes prior to the operation, and have had at least 5 years of follow-up.

ScienceDaily – Research: Potential for New Fructosamine Tests in Long-Term Diabetes Complications

Monitoring glucose levels is imperative for diabetes patients, but for some the standard Hemoglobin A1c (HbA1c) test is not valid. Researchers from Johns Hopkins University have determined that the fructosamine tests and a novel assay for glycated albumin may be useful for predicting complications related to diabetes.

Joslin Diabetes Center – New Guidelines for Blood Pressure?

The U.S. National Institutes of Health just published its 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults, [Eighth Joint National Committee (JNC 8)]. The new guidelines offer a series of changes from JNC7 which was last issued in 2003.

EndoType: Orphan Status for Type 1 Diabetes Immunotherapy

An immunotherapy for type 1 diabetes won orphan drug status from the FDA this week as it enters phase II trials. Drugmaker DiaVacs says DV-0100 halts the autoimmune reaction against islet cells by modifying a patient’s own dendritic cells and injecting them back into the body.

Johns Hopkins review throws doubt on wound care treatment

Chronic wounds are a global problem, the researchers say. In addition to obesity and diabetes worldwide, skin ulcers occur as a consequence of neurological problems, rheumatological illnesses, blood vessel inflammation and infection.